Results 121 to 130 of about 1,676,767 (268)
Retracted: Industrial Waste Water Recycling Using Nanographene Oxide Filters
Advances in Materials Science and Engineering
doaj +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
Retracted: Comparative Analysis of Natural Fibre Reinforced Composite Material Using ANSYS
Advances in Materials Science and Engineering
doaj +1 more source
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy +10 more
wiley +1 more source
Composite Materials Engineering Graduating Class Photograph: 1992
This is a class photograph of the Composite Materials Engineering Graduating Class of 1992 at Winona State University. The students in the photograph are: Mark Bennick, Dion Beyer, Thomas Brekke, David Frisch, Derrick Hongerholt, Dale Motzko, Eng Foo Ng,
Composite Materials Engineering Department-Winona State University
core
Advances in Materials Science and Engineering
doaj +1 more source
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
Retracted: Application of Nanomaterials in Visual Effects of National Costume Pattern Design
Advances in Materials Science and Engineering
doaj +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source

